Security key
403783103
GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)
CUSIP: 403783103
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 1,542,978
- Total 13F value
- $10,167,836
- Share change
- +309,817
- SEC-reported price per share
- $6.59
- Number of holders
- 21
- Value change
- +$2,041,693
- Number of buys
- 16
- Number of sells
- 2
- Shares outstanding
- 124,924,768
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
21
Top holders
10
GYRE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
GYRE THERAPEUTICS, INC. SEC filings
GYRE THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 403783103
Recent filing periods:
Ownership snapshot
Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GNI Group Ltd.
Disclosed value leader
GNI Group Ltd.
Comparable rows
15/15
Latest evidence
04 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 69%
13D/G row: GNI Group Ltd.
Showing 1-6 of 15 holder rows.
Quick read
GNI Group Ltd. leads the comparable SEC ownership view at 69%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GNI Group Ltd.'s linked filing trail.
Comparable ownership
Top 5
GNI Group Ltd.
69%
Ying Luo
8.6%
Songjiang Ma
6.3%
VANGUARD CAPITAL MANAGEMENT LLC
0.79%
BlackRock, Inc.
0.61%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GNI Group Ltd. |
13D/G
3/4/5
10%+ Owner
|
69%
|
$637,927,081
86,323,015 shares
|
$0 | 04 May 2026 |
| Ying Luo |
13D/G
3/4/5
Chief Executive Officer, Director
|
8.6%
|
$75,462,150
10,211,387 shares
|
$0 | 04 May 2026 |
| Songjiang Ma |
13D/G
3/4/5
President, Director
|
6.3%
|
$54,258,348
7,342,131 shares
|
$0 | 04 May 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.79%
|
$6,859,902
984,204 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
0.61%
|
$5,287,650
758,630 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.35%
|
$3,007,980
431,414 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
1,542,978
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q3 2025 Across Filers
Q3 2025 holders
46
Q2 2026 holders
21
Holder diff
-25
| Investor | Q3 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend